UBS O'Connor’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.98K Hold
396,500
﹤0.01% 233
2025
Q3
$37.7K Hold
396,500
﹤0.01% 243
2025
Q2
$131K Hold
396,500
﹤0.01% 309
2025
Q1
$129K Hold
396,500
﹤0.01% 259
2024
Q4
$337K Hold
396,500
0.01% 306
2024
Q3
$232K Hold
396,500
0.01% 380
2024
Q2
$383K Buy
+396,500
New +$1.9M 0.01% 379
2023
Q3
Sell
-200,000
Closed -$45K 600
2023
Q2
$45K Sell
200,000
-100,000
-33% -$846K ﹤0.01% 510
2023
Q1
$218K Sell
300,000
-500,000
-63% -$5.52M 0.01% 511
2022
Q4
$140K Buy
+800,000
New +$9.3M ﹤0.01% 660

Other funds holding MPT

UBS O'Connor's MPT Position: Q4 2016 in Review

UBS O'Connor sold out of Medical Properties Trust (MPT) in Q4 2016, closing a stake of 75,089 shares — an estimated $1.11M sold.

UBS O'Connor first reported a position in MPT in Q3 2016 and held it in 1 quarter. The position peaked at $1.11M in Q3 2016. 329 funds tracked by Wall St. Rank hold MPT as of Q4 2016.

  • UBS O'Connor reported no remaining Medical Properties Trust position as of Q4 2016 after selling out during the quarter.
  • UBS O'Connor sold 75,089 Medical Properties Trust shares in Q4 2016, an estimated $1.11M.
  • UBS O'Connor first reported a position in Medical Properties Trust in Q3 2016 and held it in 1 quarter.
  • UBS O'Connor's Medical Properties Trust position peaked at $1.11M in Q3 2016.
  • 329 funds tracked by Wall St. Rank held Medical Properties Trust as of Q4 2016.

Based on UBS O'Connor's 13F filing for Q4 2016, filed 14 Feb 2017.